Clinical Trials Logo

Clinical Trial Summary

An irreparable rotator cuff tear (IRCT) is a challenge, with a controversial definition and different treatment options. None of the latter are exempt of limitations and their survivorship is one of the concerns. In 2013, Mihata et al. proposed a novel treatment option: arthroscopic superior capsular reconstruction using a fascia lata autograft (FL-ASCR) harvested through an open approach. Although no harvest site dysfunction was reported, concerns about donor site morbidity discouraged the use of this type of graft. In 2015, the investigators modified the original FL-ASCR introducing a minimally invasive fascia lata harvesting technique, aiming to reproduce FL-ASCR's promising clinical results in IRCT, while reducing donor site morbidity.

The investigators aim to: 1) Evaluate the mid-term outcomes and donor site morbidity impact of FL-ASCR with minimally invasive harvesting; 2) Analyze the mid-term graft integrity to determine its survivorship 3) Establish clinical and imaging graft integrity correlations to guide the future treatment algorithm.


Clinical Trial Description

Task 1 - Prospective evaluation of:

1. The mid-term shoulder outcomes of ASCR with minimally invasive harvested fascia lata autograft The objective of this task is to establish the 3 years postoperative clinical and radiological shoulder outcomes of FL-ASCR with minimally invasive harvesting. The secondary purpose of this task is to test if the FL-ASCR outcomes remain constant after the 2-year evaluation.

Therefore, the FL-ASCR patients included in this study will have completed the preoperative, 6-month and 2-year postoperative evaluations and will undergo a 3-year postoperative evaluation of:

1. Bilateral shoulder active range of motion (ROM): elevation, abduction and external rotation (with the arm at the side), measured in degrees with the use of an analogic goniometer; and internal rotation, defined as the highest vertebral body that the patient's thumb can reach, converted afterwards to a scale of 1-5 points: lateral thigh=0; buttock=1; sacrum=2; lumbar=3; 12th thoracic vertebra=4; 7th thoracic vertebra=5.);

2. Bilateral shoulder strength (supraspinatus, infraspinatus, subscapularis and teres minor) measured in kilograms with the use of a digital dynamometer;

3. Bilateral functional shoulder scores: the simple shoulder test (SST, 1-12 points), the subjective shoulder value (SSV, 0-100%) and the constant score (CS, 1-100 points).

4. True anteroposterior shoulder view radiograph of the affected shoulder: the acromiohumeral interval (AHI), considering the distance between the top of the humeral head and the undersurface of the acromion, measured using a software measurement tool (PACS, Agfa HealthCare); the RCT arthritis will be graded according to the Hamada revised radiographic classification.

2. The donor site morbidity impact of FL-ASCR with minimally invasive harvesting The objective of this task is to establish the 3-year donor site morbidity subjective impact of FL-ASCR with minimally invasive harvesting. The secondary aim of this task is to test our hypothesis that the subjective impact of the donor site morbidity after FL-ASCR does not change significantly from the 2-year to the 3-year evaluation. Therefore, at the 3-year evaluation, the patients will be required to answer to the same three closed-ended questions that were asked at the 2-year evaluation to assess the donor site morbidity's impact on the patient's overall satisfaction of the surgical procedure: "Does the harvested thigh bother you?", "Does your shoulder surgery's end result compensate for your thigh's changes?", "Would you undergo the same surgery again?". Accordingly, the patients will also be asked asked, in a closed-ended questionnaire, if they noticed any of the following donor site changes: deformity, pain, numbness and specific donor site-related claudication.

Task 2 - Analysis of the mid-term graft integrity on the 3-year postoperative magnetic resonance imaging (MRI) to determine the graft mid-term survivorship

The objective of this task is to determine the 3-year postoperative survivorship of the graft, establishing the fascia lata superior capsular graft tearing rate and the most frequent site of graft failure at 3 years. A 1.5 Tesla MRI scanner (Siemens Magnetom, U.S.A.) will be used to acquire images in the coronal [proton density fat-saturated (PD FAT-SAT) and T1-weighted], sagittal (PD FAT-SAT and T2 FAT-SAT) and axial (T2* and PD) planes. We and, after blinding, two other independent experienced musculoskeletal radiologists will assess the MRI-images from each patient, in order to:

1. Identify any discontinuity of the graft which, if present, will be classified according to its site as a proximal, an intermediate or a distal tear; and as an anterior or a posterior tear.

2. Identify any discontinuity of the onlay repair of the rotator cuff remnants, which, if present, will be classified a tear of the onlay repair.

3. Grade the supraspinatus, infraspinatus, teres minor and subscapularis muscle fatty degeneration according to the Goutallier et al. classification.

4. Grade the RCT tendon remnants retraction in the coronal plane according to the Patte classification.

5. Grade the supraspinatus muscle atrophy according to the Thomazeau et al. classification.

6. Grade the supraspinatus muscle atrophy according to the tangent sign. The graft survivorship according to the three separate evaluations will be compared to establish the inter-observer reliability of the MRI graft survivorship results.

The type of progression of graft integrity will be determined by comparing the 6-month with the 3-year MRI evaluation of the graft survivorship.

Task 3 - Comparative analysis of the clinical, radiological and MRI preoperative and postoperative variables

The objective of this task is to find correlations between the graft survivorship and the results from tasks 1 and 2. The aim is to establish the clinical importance of mid-term graft survivorship.

The investigators will compare the ROM, shoulder strength, SSV, SST, CS and AHI from preoperative to 3 years postoperative; and from 2 years postoperative to 3 years postoperative (paired-samples t-test). The investigators will compare all continuous variables between the group of ASCR patients who underwent an additional onlay partial RCT repair and the group that underwent ASCR without an onlay partial RCT repair, between the anterior acromioplasty-ASCR group and the group that did not undergo an anterior acromioplasty, between the tenotomy-ASCR group and the no-LHBT group, between the preoperative and postoperative AHI<7mm group and the AHIā‰„7mm group, and between the intact-graft group and the graft-tear group (Mann-Whitney U test). The investigators will compare all categorical variables, including the donor site morbidity and overall subjective outcome results, between the groups (Fisher's exact test).

To determine the repercussion of FL-ASCR and of the graft integrity on the rotator cuff muscle function the investigators will compare the progression of the Goutallier classification of each rotator cuff muscle from preoperative to 3 years postoperative, as well as the cumulative Goutallier score (the sum of the fatty infiltration stages of the four muscles) and the global fatty muscle degeneration index (the mean value of the grades for the supraspinatus, infraspinatus, and subscapularis), between the intact-graft group and the graft-tear group.

A significant difference will be defined as P<0.05. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03663036
Study type Interventional
Source Hospital de Egas Moniz
Contact
Status Completed
Phase N/A
Start date September 5, 2018
Completion date September 4, 2019

See also
  Status Clinical Trial Phase
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Suspended NCT03290196 - The Effect of EXPAREL® on Postsurgical Pain, and the Use of Narcotics Phase 4
Active, not recruiting NCT03091075 - Oxandrolone Rotator Cuff Trial N/A
Completed NCT03380533 - Buprenorphine Transdermal Patches in Arthroscopic Rotator Cuff Repair Phase 2/Phase 3
Completed NCT04566939 - A Long Term Follow-Up of Rotator Cuff Tear Patients Treated With Integrated Complementary and Alternative Medicine
Active, not recruiting NCT02716441 - Rotator Cuff Failure With Continuity
Completed NCT03540030 - Opioid-Free Shoulder Arthroplasty Phase 4
Completed NCT02298023 - Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear) Phase 2
Completed NCT01459536 - Assessment of Muscle Function and Size in Older Adults With Rotator Cuff Tear N/A
Completed NCT02850211 - A Selective COX-2 Inhibitor Provides Pain Control But Hinders Healing Following Arthroscopic Rotator Cuff Repair Phase 4
Completed NCT01383239 - Impact of Postoperative Management on Outcomes and Healing of Rotator Cuff Repairs N/A
Completed NCT01170312 - Arthroscopic Surgery and Platelet Rich Plasma In Rotator Cuff Tear Evaluation N/A
Terminated NCT00936559 - Study Evaluating Safety Of BMP-655/ACS As An Adjuvant Therapy For Rotator Cuff Repair Phase 1
Completed NCT01204606 - Arthroscopic Rotator Cuff Repair With Multimodal Analgesia(MMA) N/A
Completed NCT00852657 - Comparison of Tendon Repair and Physiotherapy in the Treatment of Small and Medium-sized Tears of the Rotator Cuff N/A
Active, not recruiting NCT00182299 - An RCT to Compare the Outcomes of Patients With Large Rotator Cuff Repair That Undergo Repair With or Without SIS Phase 4
Recruiting NCT06120998 - Quality of Life After Arthroscopic Rotator Cuff Repair
Completed NCT05897866 - Sayed Issa's Hybrid Shoulder Arthroscopic-Open Surgical Management (HSSM) N/A
Completed NCT02644564 - Early Clinical Examination and Ultrasonography Screening of Acute Soft Tissue Shoulder Injuries N/A
Withdrawn NCT03739749 - Arthroscopic Superior Capsular Reconstruction - Study of Different Types of Grafts N/A